Polysaccharide from Sepia esculenta ink and cisplatin inhibit synergistically proliferation and metastasis of triple-negative breast cancer MDA-MB-۲۳۱ cells

سال انتشار: 1395
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 253

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-19-12_005

تاریخ نمایه سازی: 28 مهر 1400

چکیده مقاله:

Objective(s): This paper aims to investigate synergistic inhibition of polysaccharide from Sepia esculenta ink (SIP), a newly isolated marine polysaccharide in our laboratory, on breast cancer MDA-MB-۲۳۱ cells exposed to cisplatin. Materials and Methods: Cell viability of MDA-MB-۲۳۱ cells was determined by CCK ۸ assay. Median-effect concentration was analyzed using Chou-Talalay method that was also subjected to determine cell inhibition ratio and combined index, as well as interaction between SIP and cisplatin. Proliferation and migration abilities were detected with plate colony formation assay and cell wound scratch assay, respectively. Expression of MMP-۲ and MMP-۹ proteins was measured with Western blot assay. Results: Data showed that SIP not only suppressed proliferation and migration of MDA-MB-۲۳۱ cells, and expression of MMP-۲ and MMP-۹ proteins, also promoted inhibition of cisplatin on proliferation, migration and MMPs expression of MDA-MB-۲۳۱ cells, which indicates synergy inhibition of drug combination of SIP and cisplatin on breast cancer cells. The median-effect concentrations of cisplatin and SIP were ۴.۹ and ۱۶۵۹.۶ μg/ml, respectively. Whereas the concentration of combination drug was ۱۵۸.۵ μg/ml. The data indicated that drug combination can decrease dosages of the two single agents, especially the usual dosage of cisplatin. Conclusion: This research demonstrated that SIP repressed proliferation and metastasis of MDA-MB-۲۳۱ cells and promoted anticancer effect of cisplatin on the breast cancer cells. The data suggested that SIP is a potential natural drug that can be used as an auxiliary medicine alongside chemotherapy in treating breast cancer.

نویسندگان

Hua-Zhong Liu

College of Chemistry and Environment, Guangdong Ocean University, Zhanjiang ۵۲۴۰۸۸, China

Wei Xiao

Guangxi Buffalo Research Institute, Chinese Academy of Agricultural Sciences, Nanning ۵۳۰۰۰۱, China

Yi-Peng Gu

Institute of Food Science & Engineering Technology, Hezhou University, Hezhou ۵۴۲۸۹۹, China

Ye-Xing Tao

Experimental Center for Sciences, Guilin Medical University, Guilin ۵۴۱۰۰۴, China

Da-Yan Zhang

College of Food Science & Technology, Guangdong Ocean University, Zhanjiang ۵۲۴۰۸۸, China

Hui Du

Biochemisty Center, Guangdong Ocean University, Zhanjiang ۵۲۴۰۸۸, China

Jiang-Hua Shang

Guangxi Buffalo Research Institute, Chinese Academy of Agricultural Sciences, Nanning ۵۳۰۰۰۱, China

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • ۱.Smith L, Welham KJ, Watson MB, Drew PJ, Lind MJ, ...
  • ۲.Martin M. Platinum compounds in the treatment of advanced breast ...
  • ۳.Vassilomanolakis M, Koumakis G, Barbounis V, Demiri M, Panopoulos C, ...
  • ۴.Garand C, Guay D, Sereduk C, Chow D, Tsofack SP, ...
  • ۵.Luo P, Liu HZ. Antioxidant ability of squid ink polysaccharides ...
  • ۶.Le XY, Luo P, Gu YP, Tao YX, Liu HZ. ...
  • ۷.Le XY, Luo P, Gu YP, Tao YX, Liu HZ. ...
  • ۸.Liu C, Li X, Li Y, Feng Y, Zhou S, ...
  • ۹.Chen S, Wang J, Xue C, Li H, Sun B, ...
  • ۱۰.Zong A, Liu Y, Zhang Y, Song X, Shi Y, ...
  • ۱۱.Zong A, Zhao T, Zhang Y, Song X, Shi Y, ...
  • ۱۲.Zuo T, Cao L, Xue C, Tang QJ. Dietary squid ...
  • ۱۳.Zuo T, He X, Cao L, Xue C, Tang QJ. ...
  • ۱۴.Zuo T, Cao L, Li X, Zhang Q, Xue C, ...
  • ۱۵.Chou TC. Theoretical basis, experimental design, and computerized simulation of ...
  • ۱۶.Chou TC. Drug combination studies and their synergy quantification using ...
  • ۱۷.Liu HZ, Tao YX, Luo P, Deng CM, Gu YP, ...
  • ۱۸.Dawood S. Triple-negative breast cancer: Epidemiology and management options. Drugs ...
  • ۱۹.Ressler S, Mlineritsch B, Greil R. Triple negative breast cancer. ...
  • ۲۰.Hatzopoulos S, Di Stefano M, Campbell KM, Falgione D, Ricci ...
  • ۲۱.Liedert B, Materna V, Schadendorf D, Thomale J, Lage H. ...
  • ۲۲.Jia Y, Zhang C, Zhou L, Xu H, Shi Y, ...
  • ۲۳.Radin D, Lippa A, Patel P, Leonardi D. Lifeguard inhibition ...
  • ۲۴.Takaya Y, Uchisawa H, Narumi F, Matsue H. Illexins A, ...
  • ۲۵.Chen SG, Xu J, Xue CH, Dong P, Sheng WJ, ...
  • ۲۶.Thorns V, Walter GF, Thorns C. Expression of MMP-۲, MMP-۷, ...
  • نمایش کامل مراجع